214 related articles for article (PubMed ID: 32314665)
61. Loss of NKCC1 function increases epithelial tight junction permeability by upregulating claudin-2 expression.
Koumangoye R; Penny P; Delpire E
Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1251-C1263. PubMed ID: 35968893
[TBL] [Abstract][Full Text] [Related]
62. IL-1β strengthens the physical barrier in gingival epithelial cells.
Stolte KN; Pelz C; Yapto CV; Raguse JD; Dommisch H; Danker K
Tissue Barriers; 2020 Jul; 8(3):1804249. PubMed ID: 32835592
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of different toxicity assays applied to proliferating cells and to stratified epithelium in relation to permeability enhancement with glycocholate.
Eirheim HU; Bundgaard C; Nielsen HM
Toxicol In Vitro; 2004 Oct; 18(5):649-57. PubMed ID: 15251183
[TBL] [Abstract][Full Text] [Related]
64. A primary culture model of rabbit conjunctival epithelial cells exhibiting tight barrier properties.
Saha P; Kim KJ; Lee VH
Curr Eye Res; 1996 Dec; 15(12):1163-9. PubMed ID: 9018430
[TBL] [Abstract][Full Text] [Related]
65. Activation of the epithelial-to-mesenchymal transition factor snail mediates acetaldehyde-induced intestinal epithelial barrier disruption.
Elamin E; Masclee A; Troost F; Dekker J; Jonkers D
Alcohol Clin Exp Res; 2014 Feb; 38(2):344-53. PubMed ID: 24033729
[TBL] [Abstract][Full Text] [Related]
66. Epithelial transport of drugs in cell culture. VIII: Effects of sodium dodecyl sulfate on cell membrane and tight junction permeability in human intestinal epithelial (Caco-2) cells.
Anderberg EK; Artursson P
J Pharm Sci; 1993 Apr; 82(4):392-8. PubMed ID: 8468683
[TBL] [Abstract][Full Text] [Related]
67. Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies.
Yoo JW; Kim YS; Lee SH; Lee MK; Roh HJ; Jhun BH; Lee CH; Kim DD
Pharm Res; 2003 Oct; 20(10):1690-6. PubMed ID: 14620527
[TBL] [Abstract][Full Text] [Related]
68. Raptor knockdown concurrently increases the electrical resistance and paracellular permeability of Caco-2 cell monolayers.
Kaur H; Moreau R
Life Sci; 2022 Nov; 308():120989. PubMed ID: 36152680
[TBL] [Abstract][Full Text] [Related]
69. Temperature corrected transepithelial electrical resistance (TEER) measurement to quantify rapid changes in paracellular permeability.
Blume LF; Denker M; Gieseler F; Kunze T
Pharmazie; 2010 Jan; 65(1):19-24. PubMed ID: 20187574
[TBL] [Abstract][Full Text] [Related]
70. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
71.
Chen W; Alshaikh A; Kim S; Kim J; Chun C; Mehrazarin S; Lee J; Lux R; Kim RH; Shin KH; Park NH; Walentin K; Schmidt-Ott KM; Kang MK
J Dent Res; 2019 Sep; 98(10):1150-1158. PubMed ID: 31340691
[TBL] [Abstract][Full Text] [Related]
72. Mucin dispersions as a model for the oromucosal mucus layer in in vitro and ex vivo buccal permeability studies of small molecules.
Marxen E; Mosgaard MD; Pedersen AML; Jacobsen J
Eur J Pharm Biopharm; 2017 Dec; 121():121-128. PubMed ID: 28974436
[TBL] [Abstract][Full Text] [Related]
73. Validation of in vitro cell culture models of the blood-brain barrier: tightness characterization of two promising cell lines.
Neuhaus W; Plattner VE; Wirth M; Germann B; Lachmann B; Gabor F; Noe CR
J Pharm Sci; 2008 Dec; 97(12):5158-75. PubMed ID: 18399537
[TBL] [Abstract][Full Text] [Related]
74. Interleukin-1β induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood-brain barrier model.
Labus J; Häckel S; Lucka L; Danker K
J Neurosci Methods; 2014 May; 228():35-45. PubMed ID: 24631939
[TBL] [Abstract][Full Text] [Related]
75. Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650.
Ladel S; Schlossbauer P; Flamm J; Luksch H; Mizaikoff B; Schindowski K
Pharmaceutics; 2019 Aug; 11(8):. PubMed ID: 31374872
[TBL] [Abstract][Full Text] [Related]
76. Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier.
Watson PM; Paterson JC; Thom G; Ginman U; Lundquist S; Webster CI
BMC Neurosci; 2013 Jun; 14():59. PubMed ID: 23773766
[TBL] [Abstract][Full Text] [Related]
77. Establishment of an in vitro brain barrier epithelial transport system for pharmacological and toxicological study.
Shi LZ; Zheng W
Brain Res; 2005 Sep; 1057(1-2):37-48. PubMed ID: 16126179
[TBL] [Abstract][Full Text] [Related]
78. Development of a model for functional studies of ABCG2 (breast cancer resistance protein) efflux employing a standard BeWo clone (B24).
Crowe A; Keelan JA
Assay Drug Dev Technol; 2012 Oct; 10(5):476-84. PubMed ID: 22681401
[TBL] [Abstract][Full Text] [Related]
79. The Path from Nasal Tissue to Nasal Mucosa on Chip: Part 1-Establishing a Nasal In Vitro Model for Drug Delivery Testing Based on a Novel Cell Line.
Bendas S; Koch EV; Nehlsen K; May T; Dietzel A; Reichl S
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765214
[TBL] [Abstract][Full Text] [Related]
80. Toll-like receptor 2 stimulation augments esophageal barrier integrity.
Ruffner MA; Song L; Maurer K; Shi L; Carroll MC; Wang JX; Muir AB; Spergel JM; Sullivan KE
Allergy; 2019 Dec; 74(12):2449-2460. PubMed ID: 31267532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
